MYRIAD GENETICS, INC.
-
Open
20.07
-
Previous Close
20.61
-
Volume (Avg)
465.70k (488.68k)
-
Day's Range
20.07-21.02
-
52Wk Range
16.02-33.09
-
Market Cap.
1.68B
-
Dividend Rate ( Yield)
-
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
581.41 (-)
Top Stories
-
Here's Why Investors Should Hold Myriad Genetics (MYGN) Now
Nasdaq 9/26/2022Myriad Genetics, Inc. MYGN has been gaining from continuous recovery in testing volumes. The robust revenue contribution from the company’s proprietary myChoiceCDx test is impressive.
-
Myriad Genetics, Inc. (NASDAQ:MYGN) Shares Sold by Amalgamated Bank
Defense World -
Myriad Genetics, Inc. (NASDAQ:MYGN) Holdings Increased by State of Alaska Department of Revenue
Defense World -
Myriad Genetics, Inc.
U.S. News & World Report -
Myriad: Trying To Find Its Footing In An Evolving Industry
Seeking Alpha 9/26/2022Given the present macroeconomic disturbances, one would be inclined to seek safety in defensive healthcare companies, but I don't think Myriad Genetics, Inc. (NASDAQ:MYGN) is an ideal choice.
-
Understanding Inherited Cancer Risk and Genetic Testing
Yahoo -
Genetic tests for breast cancer patients sow confusion
CBS News -
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
WAVY-TV -
The power of predictive genetic testing
BBC -
Myriad Genetics, Inc. Common Stock (MYGN)
Nasdaq -
Getting ahead of hereditary cancers through predictive diagnostics
BBC -
Lung Cancer Diagnostic and Screening Market to Offer Lucrative Growth Prospects for Manufacturers by 2028 | Myriad Genetics, NanoString
Medgadget -
Myriad Genetics Partners with Institut für Hämopathologie Hamburg and Centre Georges-Francois LeClerc to Expand Access to Genetic Testing in Europe
Yahoo Style Canada -
Here's Why Investors Should Hold Myriad Genetics (MYGN) Now
Yahoo News -
Myriad Genetics Inc
Reuters 9/8/2022Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company primarily provides testing and collaborative development of testing that is designed to assess an individual ...
-
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
Yahoo Finance -
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
Fox2Now St. Louis -
MYGN Myriad Genetics, Inc.
Seeking Alpha
